ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Lonza to join biologics hub in China

by Rick Mullin
December 16, 2018 | APPEARED IN VOLUME 96, ISSUE 49

 

Lonza will join a biomanufacturing initiative between GE Healthcare and China’s Guangzhou Development District by installing what GE calls an “off-the-shelf biologics factory” in Guangzhou. Lonza and GE will codesign the 17,000 m2 facility. The Swiss pharmaceutical services firm intends to debut antibody production there by 2020 using GE’s 1,000 and 2,000 L disposable bioreactors. The facility will offer services including cell-line construction and gene expression.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment